Stem cells play a critical role in normal tissue maintenance, and mutations in these stem cells may give rise to cancer. We hypothesize that melanoma develops from a mutated stem cell and therefore residual stem cell characteristics should be able to be identified in melanoma cell lines. We studied three metastatic melanoma cell lines that exhibited multiple morphologic forms in culture and demonstrated the capacity to pigment. We used the ability to efflux Hoechst 33342 dye, a technique known to enrich for stem cells in many tissues, to segregate cell populations. The cells with the greatest ability to efflux the dye were (1) small in size, (2) had the capacity to give rise to larger cell forms, and (3) had the greatest ability to expand in culture. The small cells were found to have a decreased proliferative rate and were less melanized. Large dendritic cells that appeared to be nonproliferative were identified in cultures. Treatment with cytosine b-D-arabinofuranoside hydrochloride (Ara-C) expanded the large cell population but the residual proliferative capacity, both in vitro and in vivo, remained concentrated in the smaller cell fraction. Antigenic staining patterns were variable and heterogeneous. Nestin (a neural stem cell marker) and gp100 (premelanosomal marker) favored the smaller cell population, while nerve growth factor receptor often labeled larger cells. Morphologic and antigenic heterogeneity remained intact after clonal purification. These findings are consistent with the behavior expected for a tumor based on stem cell biology; this finding has diagnostic and therapeutic implications for melanocytic neoplasias.
INTRODUCTION
The epidermal melanocyte is currently thought to serve as the origin for acquired benign and malignant melanocytic neoplasias (Bennett, 2003; Hussein, 2004) . A stepwise ''dedifferentiation'' process has been proposed for the development of melanoma in which the mutated melanocyte passes through benign nevus, dysplastic nevus, melanoma radial growth, melanoma vertical growth, and metastatic melanoma stages (Clark et al., 1984; Herlyn et al., 1985 Herlyn et al., , 1987 . However, clinically, the majority of melanomas do not evolve in pre-existing dysplastic nevi and many evolve in normal appearing skin (Kelly et al., 1997; Lucas et al., 2003) . An alternative theory has been put forth (Cramer, 1984a, b) , suggesting that melanocytic neoplasias are derived from immature melanocytic cells.
Immature melanocytic cells are present in normal human epidermis (Grichnik et al., 1996) , and melanocytic stem cells have been identified in the murine hair follicle (Nishimura et al., 2002) . A growing body of literature has established the role of stem cells in normal tissue homeostasis (Reya et al., 2001; Brittan and Wright, 2002; Alonso and Fuchs, 2003) . Stem cells are slowly proliferative cells that give rise to more rapidly proliferative cells (transiently amplifying (TA) cells) that eventually fully differentiate into mature tissue components. Although much remains to be understood about normal melanocyte turnover, it is reasonable to assume that melanocytes in the human skin are normally replenished from a reservoir of immature cells. This is supported clinically by (1) disease processes such as vitiligo where differentiated melanocytes are destroyed, but when the disease is controlled, new melanocytes appear (Yu, 2002) , and (2) hair cycling experiments where hair bulb melanocytes appear to undergo apoptosis but are replenished by melanocytic cells in the outer root sheath, with hair regrowth (Tobin et al., 1998; Nishimura et al., 2002; Botchkareva et al., 2003) . Since cells with the capacity to proliferate and differentiate into melanocytes exist in the skin, their role should be considered in our models of melanocytic neoplasia.
Evidence continues to mount for the role of stem cells in cancer (Reya et al., 2001) . Cells with stem cell-like features have been identified in a number of human malignancies (Wulf et al., 2001; Al-Hajj et al., 2003; Singh et al., 2003; Kondo et al., 2004) . Leukemia lines have been noted to include cells with stem cell-like features (Wulf et al., 2001) .
Breast cancer stem cells have been identified through expression of a unique set of cell markers and have been shown to have the greatest potential to form tumors in an animal system (Al-Hajj et al., 2003) . Glial tumor stem cells have been shown to have the capacity to differentiate into both glial and neuronal cell forms (Kondo et al., 2004) .
Theoretically, if mutational events occur in stem cells giving rise to melanocytic neoplasias, then it is reasonable to assume that these mutated cells would attempt to continue to follow normal differentiation pathways until they accumulated sufficient genetic damage that this was no longer possible. However, if the mutational events occur in mature melanocytic cells, the resulting tumor cells would be expected to be more aggressive than the original cell and expand in a homogeneous manner until additional mutations created new clones that would then repeat the clonal selection process.
We hypothesize that the mutagenic event that gives rise to melanoma occurs within a stem cell and not within a differentiated melanocyte. In the following experiments, we will demonstrate that melanoma tumors exist that have characteristics that are consistent with a tumorigenesis event based on a mutant stem cell.
RESULTS

Metastatic melanoma lines stably maintain multiple morphologies
Given the hypothesis that melanomas are derived from mutant stem cells, it should be possible to identify cell lines that retain residual characteristics of this population. We selected three cell lines from our collection, DM1N, DM2N, and DM3N, that appeared to be good candidates for the discrimination of stem-cell-like properties (Figure 1 ). All three cell lines were originally isolated from lymph node melanoma metastases. Microscopic examination revealed cells with different morphologies including small ovoid, spindle, flat polygonal, and large dendritic forms (Figure 1a , c, and e). Multinucleated cells were also noted. These multiple cell morphologies persisted, despite more than 1 year of continued passage in culture. Visible melanin production was increased if the cells were maintained under confluent conditions (Figure 1b, d , and e). Tumor cell spheroids also developed under confluent conditions. Lines DM1N and DM3N increased pigmentation readily once confluent, and DM2N required longer-term cultures.
The very existence of melanoma lines that retain the capacity to pigment and exhibit multiple cell forms in culture despite continued passage supports the concept of an origin based on a stem cell lineage. These cell lines were then used for further investigation.
Hoechst dye-low cells are small in size, give rise to larger cell forms, and have a growth advantage in mixed culture
We sought an experimental approach that would allow for separation of the larger and smaller cell forms. One of the approaches was to use Hoechst dye efflux. The active efflux of a vital dye, Hoechst 33342, has been shown to identify a dye-low population of cells (side population) enriched in stem cells in the bone marrow (Goodell et al., 1996) , in other tissues (Asakura and Rudnicki, 2002) , and in some tumor cell lines (Kondo et al., 2004) . In neonatal foreskin, this technique has also revealed a rare subpopulation of melanocytic cells (Terunuma et al., 2003) .
The flow cytometry plot of Hoechst dye fluorescence in the blue and red revealed a continuum of cells ranging from dye-low to dye-high components for the three melanoma lines. Overlying the primary collection of cells was a faint secondary collection of cells (separation between the two cell masses is indicated by the white arrows in Figure 2 ). DNA content analysis revealed that the upper cell mass had increased DNA content consistent with cells in the S/G2/M stages of the cell cycle (data not presented). The dye-low cells in most tissues demonstrate sensitivity to verapamil but some tissues, such as brain (Asakura and Rudnicki, 2002) , have resistant subpopulations. Verapamil was noted to inhibit the ability to efflux the dye, with the three lines exhibiting differential sensitivity with a 33, 81, and 100% decrease in the gated dye-low population for DM1N, DM2N, and DM3N, respectively (Figure 2b , d, and f).
Cells with the greatest ability to efflux the Hoechst dye (dye-low cells) were isolated and found to be small in size. Culture of these small cell forms, in dilute conditions, revealed slow growth with the eventual appearance of larger cell forms (Figure 3) . In order to study the contribution of these dye-low cells to overall culture growth, we stably labeled duplicate cultures of the three lines with green fluorescent protein (GFP) using a lentivirus system. Together with the original unlabeled cultures, this allowed us to study the impact of individual cells within the larger population through mixing experiments. We isolated GFP-labeled cells from the dye-low and dye-high regions of the primary population of Hoechst dyestained cells, further purified by resorting a second time, and introduced them into nonsorted, nonlabeled cultures of the same tumor type ( Figure 4 ). At 24 hours, the introduced cells had expanded beyond their original dye-low and dye-high compartments (Figure 4e and f). The total percentage of GFP cells was similar for the dye-low and dye-high mixed cultures on day 1 (Figure 4g and h, green line). The dyehigh cultures rapidly lost cells in the dye-high compartment ( Figure 4h , blue line) and equilibrated to approximately equal percentages of GFP cells in all the compartments (Figure 4h , red, blue, and green lines) within 1 week. In contrast, the percentage of dye-low GFP cells (Figure 4g , red line) increased in the dye-low cultures and equilibrium was not achieved for months. The dye-low cells led to a greater increase in the overall percentage of GFP cells with a maximum of 1.8-, 2.6-, and 4.7-fold over the dye-high cells for DM1N, DM2N, and DM3N, respectively. At extended time points, GFP-positive cells decreased. It is not entirely clear why this occurred, but it was a repeatable phenomenon, potentially due to either GFP toxicity, GFP downregulation, or a GFP expression selection basis.
Small cells exhibit a lower proliferative rate
The delayed equilibrium of the dye-low cells as compared to the dye-high cells suggested a difference in proliferative rate. As the dye-low cells were small in size and the dye-high cells were large, these size differences allowed us to evaluate proliferation differences directly in culture. For these experiments, we labeled cells actively synthesizing DNA during a 90-minute period with BrdU. Nuclear size appeared to correlate with overall cell size and BrdU incorporation was noted in the nuclei of both small and large cells ( Figure 5 ). The cells were imaged (100-200 cells per field) and nuclei scored as large or small based on a template designed to split the population roughly in half (data are presented 7SD of nuclear counts for four representative microscopic fields). The nuclei were segregated into either small or large categories, with 4975, 6178, and 5974% of the nuclei considered small in DM1N, DM2N1, and DM3N, respectively. The data for the BrdU incorporation are presented graphically in Figure 5d . Large cells were found to be actively synthesizing DNA at approximately twice the rate of the small cells.
To further verify the difference in proliferation between the cell sizes, we segregated the cells on the basis of low and high content of a vital cytoplasmic dye, cell tracker orange (CTO). Unlike the DNA staining Hoechst dye, the CTO dye is independent of DNA amount. This method was very effective in segregating the small and large cell populations ( Figure 6 ). The large cell population included heavily melanized large dendritic cells ( Figure 6 ). DNA quantification analysis revealed S/G2/M to G1/G0 ratios of 11.9, 51.4, and 19.3% for the total population, 2.8, 15.6, and 9.5% for the small cell fraction (smallest 5%) and 43.8, 70.4, and 47 .5% for the large cell fraction (largest 5%) respectively for DM1N, DM2N, and DM3N. This confirmed marked differences in the proliferative rates between the small and large cells.
One concern was whether the difference in proliferative rate could be largely due to the dynamics of cell division, with small cells having to grow to large cells before division. To address this concern, we mixed small and large CTOlabeled cell fractions with unsorted GFP cells and followed the cultures. At 48 hours, dividing cells could be identified for both small and large cell forms ( Figure 7) . Therefore, small cells are not merely the progeny of large cells, requiring growth to a larger cell size before division can recur. These mixed cultures were followed for approximately 3 months with flow cytometry to identify whether segregation by the CTO dye would also reveal differences in the overall contribution of the small and large components to tumor growth. The small cell component demonstrated a 2.2-, 5.9-, and 2.0-fold maximum increase over the large cell component for DM1N, DM2N, and DM3N, respectively.
These efforts demonstrated that the small cell component is less proliferative than the large cell component but, despite this, it retains a greater capacity to expand in culture.
Melanoma lines display antigenic heterogeneity
Given the heterogeneous cell morphology, it was of interest to determine whether the lines would be found to be antigenically heterogeneous and whether antigenic markers segregated with small or large cell forms. At the outset, it became clear that these cultures were antigenically very dynamic. Major factors influencing this appeared to include tissue culture surface, media change rate, cell density, and duration in culture. Confluent cultures seemed to be the most stable and were used for the experiments presented. Mechanically detached cells for the three lines were double labeled with Nestin/gp100 and nerve growth factor receptor (NGFR)/gp100 ( Figure 8 ). Overall, nestin and gp100 favored the smaller cell population while NGFR often labeled larger cells. A few nestin-positive cells with very bright staining were noted that did not also coexpress high levels of gp100. Cells were also noted in the culture system that failed to stain for either antigen (Figure 8a , c, and e). Heterogeneous staining was also noted for Mart-1, smooth muscle actin, and KIT (present on DM2N) (data not shown).
Terminally differentiated large dendritic cells can be identified and this population can be expanded with Ara-C treatment
In order for the small cells to contribute to a greater extent to the tumor bulk, the larger cells must eventually cease proliferation and be lost from the tumor environment. In an effort to identify cells that had ceased proliferation, we labeled the cells with the CTO dye and followed the cultures over time. The dye was progressively diluted in the cells undergoing cell division. After 6 days, most of the cells in the culture had diluted the dye and a subpopulation of brightly staining large dendritic cells was revealed ( Figure 9 ). Lacking evidence of further cell division, these cells were interpreted as terminally differentiated. These terminally differentiated cells were rare and we sought mechanisms to expand this subpopulation in order to further study the subgroup of cells. In order to accomplish this task, we utilized a DNA synthesis inhibitor, cytosine b-Darabinofuranoside hydrochloride (Ara-C). Cultures treated with Ara-C for 3 days retained 3774, 270.2, and 3873% of the total number of cells present in matched control cultures, for DM1N, DM2N, and DM3N, respectively. The majority of the retained cells in the Ara-C-treated cultures were of greater size and dendricity than the cells in the nontreated control cultures. The Ara-C-treated and normal control cells were trypsinized, concentrated, and replated. At 1 day after the plating, the normal control cells had 9274, 8577, and 12274% of the plated counts and, on day 7, these cells had expanded to 1,520780, 2,0267201, and 1,6957150% of the plated cell numbers. In contrast, the Ara-C-treated cells had 4374, 3171, and 6475% of the plated counts on day 1 and revealed a modest decline with 3276, 1471, and 5678% of the plated cell numbers remaining at day 7. Thus, the large dendritic differentiated cells in the Ara-C-treated cultures persisted but did not appear to proliferate and were slowly lost from the culture environment as would be expected for terminally differentiated cells. However, with longer culture times, colonies of smaller cell forms began to become apparent, suggesting that there was a subpopulation of cells that had survived the Ara-C treatment. Residual growth capacity remains concentrated in the small cell compartment after treatment with Ara-C
In order to demonstrate that residual proliferation capacity was retained in a resistant subpopulation of small cells and was not due to ''de-differentiation'' of the large dendritic cell forms, we segregated the small and large cell populations and followed them for growth capacity both in vitro and in vivo. DM1N and DM3N were treated continuously with Ara-C for 5 days. Owing to toxicity, DM2N was given normal media on days 3 and 4. The treated cultures were allowed 1 day to recover in normal media (day 6) before cell sorting. The cells were stained with CTO and were sorted into large (CTO-high) and small (CTO-low) cell fractions. For the in vitro experiments, the sorted small and large cell fractions were plated at equal numbers, followed in culture, and harvested together when sufficient cell numbers had recovered (Figure 10a-f ). Compared to the large cell component, the small cell component included the vast majority of cells with growth potential (Figure 10 , right panel), suggesting that recovery was occurring from resistant small cells and was not due to ''de-differentiation'' from the larger cell forms.
We also chose to verify that this phenomenon occurs in vivo, by utilizing a murine window system in which cells can be injected and followed (Shan et al., 2004) . For these studies, Ara-C-treated, GFP-labeled cells, sorted into CTOlow (small cell) and CTO-high (large cell) populations, were used. For DM3N, there were three surviving mice with CTOlow injected windows and four with CTO-high injected windows. Two of the three CTO-low grafts retained cells while only one of the four CTO-high grafts retained cells. DM3N CTO-low and CTO-high grafts with retained cells are presented (Figure 11 ). At day 4, the retained injected DM3N GFP-labeled cells were relatively equivalent, but by day 21, the CTO-high (large cell fraction) diminished in size, while the CTO-low (small cell fraction) expanded. Transillumination demonstrated pigment deposition at the large cell (CTOhigh) injection site and an amelanotic tumor mass at the small cell (CTO-low) injection site. Treated cells from the other two lines largely failed to survive in the window system, suggesting a need for further understanding of the effect of the murine environment on the human tumor cell lines, and the need to further optimize the cell treatment protocol. Nevertheless, the results with the DM3N cell line suggest that it is possible to segregate fractions of cells from melanoma tumors that have different tumor-forming capacities.
Purified single tumor cells retain capacity to give rise to heterogeneous cultures
If the tumor is based on a mutant stem cell, then the heterogeneous characteristics should be maintained in cultures established from a single tumor cell. If the tumor is based on a ''de-differentiation'' process and heterogeneity is due to accumulation of different mutant clones, then single- cell cloning should initially give rise to a uniform cell population. We sought to clone each line from a single cell but unfortunately found that single cells do not survive well on their own. We utilized our GFP-labeled tumor cells to overcome this hurdle. Non-GFP-labeled cells for each tumor line were sorted into 96-well plates (30 cells per well) as feeder cells. This was followed by the introduction of a single GFP þ cell (matched for the specific tumor line, sorted from the whole culture based on adequate GFP signal) into each well. The majority of cells failed to survive, resulting in only scattered positive wells often with only one obvious colony. GFP-positive colonies were expanded. These colonies were then subjected to flow cytometric purification, to exclude possible contaminating non-GFP cells. The resultant lines, expanded from a single GFP-labeled melanoma cell, are illustrated ( Figure 12 ) and were found to retain the ability to sustain multiple morphologic forms. These cells also retained the ability to pigment at higher densities and exhibited antigenic heterogeneity (data not presented).
DISCUSSION
These studies were undertaken to determine if residual stem cell characteristics could be identified in metastatic melanoma cell lines. We have identified metastatic melanoma cell lines that are heterogeneous, both in cell morphology and antigenic characteristics even after long-term culture and single-cell cloning. Within these cultures, we have identified smaller cells that are Hoechst 33342 dye-low and have the capacity to give rise to larger cell morphologies. Despite a slower proliferative rate of the small cell population, these cells demonstrated an increased capacity to drive cellular expansion in culture. Larger dendritic, pigmented, nonproliferative cell forms could be identified and expanded in the presence of Ara-C. These findings are consistent with the biologic processes that would be anticipated for a tumor based on a mutant stem cell attempting to undergo normal developmental processes. The metastatic melanoma cultures were found to include cells with different morphologies including small ovoid, bipolar, flat polygonal, and large dendritic forms. These features were maintained even after single-cell cloning. This is consistent with a mutated cell attempting to follow normal melanocytic developmental pathways. Similar cell morphologies including small nonpigmented and larger pigmented forms have been noted in primary cultures of murine melanocytic cells (Sviderskaya et al., 1995) . In human skin, at least three different phenotypic stages of melanocytes can be identified in hair follicle studies, including nonpigmented and pigmented proliferative cell forms as well as heavily pigmented nonproliferative cell forms (Tobin and Bystryn, 1996) . Thus, the continued formation of differentiating cell forms is consistent with normal developmental biology. The Hoechst dye studies allowed us to segregate small and larger cell forms. The populations best at effluxing the Hoechst dye have been noted to be enriched for stem cell capacity (Goodell et al., 1996) . The ability of cells to efflux the Hoechst dye is thought to be primarily due to the activity of ATP-binding-cassette transporters (Zhou et al., 2001) . In the literature, the dye-low population is generally presented as a minor group of cells (termed side population) projecting from a larger mass of cells and extending toward the origin on the flow cytometry plot. In our experiments, the bulk of the cultured cells appeared to form this structure. Verapamil sensitivity is often used to confirm this population by inhibiting the cell's ability to efflux the dye. All three lines demonstrated sensitivity to verapamil, with DN3N demonstrating a marked response, DM2N a moderate response, and DM1N a mild response. It has been noted that some tissues such as brain (Asakura and Rudnicki, 2002) have verapamil-resistant subpopulations. It is possible that the different response levels seen in our lines are due to differences in the transporters expressed. Melanoma appears to be unusual in the amount of cells capable of effluxing the Hoechst dye, and it is possible that melanoma includes a larger percentage of stem-cell-like cells than other tumors studied (Kondo et al., 2004) . In support of this possibility, nuclei from melanoma cells were found to be able to give rise to embryonic stem cells that were then able to differentiate into melanocytic, lymphocytic, and fibroblastic cells in nuclear transplantation studies (Hochedlinger et al., 2004) . Nuclei transplanted from leukemia, lymphoma, and breast cancer cells failed to give rise to embryonic stem cells.
The melanoma cells with the greatest Hoechst efflux capacity were small in size and gave rise to larger cell forms. The small cells were also found to have a decreased proliferative rate compared to the larger cells (lower percentage of BrdU-positive nuclei and DNA profiles with decreased percentage of cells in S/G2/M phases of the cell cycle) and were found to be fully competent of cell division (not just recently divided large cells). The differences in proliferative rate are consistent with stem-cell to transientamplifying-cell biology. It is notable that an increased proliferative rate has been reported for pigmented melanocytes compared to the nonpigmented melanoblast population from which they were derived (Sviderskaya et al., 1995) . Differences in cell size may be dependent of the type of cell the tumor is ultimately attempting to differentiate toward. A small size for stem cells has been reported for hepatic stem cells and glioma cells (Xiao et al., 2003; Kondo et al., 2004) .
The small cells also had the greatest ability to expand in culture, but this was a slow process requiring months instead of days. This phenomenon was consistent with the behavior that would be expected for a stem-cell-based system requiring the more rapidly proliferative cells to ultimately terminally differentiate and be lost from the system before being replaced by progeny of the underlying stem cell compartment. The CTO dilution studies indicated that nonproliferative large dendritic cells were present in the culture system but were relatively rare. This may explain why the difference obtained between the small and large cell compartments in the untreated cells was only two-to fivefold. In addition to a paucity of differentiated cells, there may also be some capacity for cells in the TA population to return to stem cell status. In support of this concept, melanocyte stem cells have been shown to give rise to TA cells and some of those TA cells appeared to be able to revert to stem cells (Nishimura et al., 2002) . The Hoechst dye experiments were able to give us some insight into the process. It is of interest that in the experiments in which we added GFP-labeled dyehigh cells, some of these cells appeared to repopulate the dye-low region. Thus, some cells appear to have some capacity to interconvert between cell states. However, cells also appear to cross a threshold and terminally differentiate. This is supported by the Ara-C experiments. Sorting of the treated cultures revealed dramatic differences in the growth capacity between small and large cell compartments. Taken together, these experiments suggest that under the normal DM2N (b) , and DM3N (c) were labeled with CTO and followed in culture over time. The CTO dye was progressively lost from the majority of the cells but the staining persisted in scattered large dendritic cells (arrows). These images were taken 6 days after CTO labeling. Bar ¼ 100 mm.
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culture conditions, the majority of melanoma cells are in the stem cell/TA state and that some interconversion between the states is possible. Eventually, the cells terminally differentiate and are lost from the system, allowing the stem cell compartment to expand.
Ideally, antigenic markers will be identified that will detect the most stem-cell-like melanoma cells. However, as melanocytes have been derived from embryonic stem cells (Yamane et al., 1999) , neural crest cells (Kawa et al., 2000; Kawakami et al., 2002) , and melanoblasts (Sviderskaya et al., 1995) , these markers could lie anywhere along the developmental pathway and may be different for different melanoma tumors. More primitive pluripotent stem cells may have mutations that favor the melanocytic pathway, but the tumor stem cell itself may have greater latitude in the type of cellular pathways it can activate, allowing for more plasticity and potentially a more aggressive tumor. This hypothesis could account for findings such as vascular mimicry in aggressive melanoma tumors (Hendrix et al., 2003) . For the three lines in this study, the staining patterns were found to be dynamic and varied, dependent on the culture conditions. We presented data from confluent cultures, speculating that the confluent conditions would be most similar to the in vivo tumor environment (high cell-to-cell interaction and autocrine/paracrine factor levels). Of the markers studied, NGFR was the one most likely to be found on the larger cell forms. The pre-melanosomal marker gp100 was variably expressed favoring the smaller cell forms. Similar findings were also noted for mart-1. The most interesting finding centered on the neural stem cell marker, nestin. This marker has been reported to be a marker of pluripotent stem cells (Wiese et al., 2004) . While colocalization with the pre-melanosomal marker was noted, the cells staining most intensely for nestin had very little obvious gp100. While it is tempting to speculate that these brightly staining nestin-positive cells are the melanoma tumor stem cells, the high degree of staining variability, including some circumstances in which they are virtually absent, suggests that we need a better understanding of the dynamics and control of environment before we can fully elucidate its value. The presence of nestin staining opens the door for the evaluation of a vast number of potential markers to further elucidate the stem cell biology of melanoma tumors.
There are several attractive features of the stem cell hypothesis for melanocytic neoplasia. First, melanocytic nevi and melanoma would both have a common origin, being derived from a genetically defective stem cell. The severity of the defect in growth regulation would determine the extent of overgrowth; self-limiting defects would be benign, while nonlimiting defects would be malignant. An additional mutation could occur during the evolution of a benign neoplastic process, resulting in a malignant subclone, but this would not be required. Second, the concept of ''dedifferentiation'' could be retired. Rather than melanoma ''de-differentiation'' from a melanocyte, the gross perception of de-differentiation could merely be due to the unmasking of a malignant stem/precursor cell with decreased ability to produce competent differentiated daughter cells. Third, metastasis could be based on the more primitive stem cell biology, which may include its small size and differences in cell adherence. Fourth, delayed onset and tumor dormancy may be more easily explained. Cells could exist unstimulated for long periods in the body, and then when environmental conditions are appropriate, the mutated stem cells could again give rise to TA/differentiating daughter cells and the tumor would become apparent. Fifth, death from melanoma despite a strong immunologic response to melanocytic antigens can also be more easily explained. While the daughter cells might be easily destroyed by the immune system, the malignant stem-like cells might be overlooked. Thus, a number of known biologic characteristics of melanomas support the theory that they may have originated from a mutated stem cell.
In summary, we believe that the stem cell model is consistent with our clinical knowledge of melanoma and normal biology and inconsistent with ''de-differentiation''. This stem cell model has diagnostic, prognostic, and therapeutic ramifications.
MATERIALS AND METHODS
Cell lines and culture
Melanoma cells were obtained from patients' lymph node metastases under IRB-approved protocols (HFS). Three metastatic melanoma lines were selected for study and referred to as DM1N, DM2N, and DM3N. The cell lines were maintained in MEM (supplemented with 2 mM L-glutamine, antibiotic-antimycotic, and 5% fetal bovine serum) in Costar vented Tissue Culture flasks (Corning, New York, NY) at 371C in a humidified 5% CO 2 environment. Media were changed every 48 hours. All tissue culture reagents were obtained from Gibco (Grand Island, NY). Ara-C (Sigma, St Louis, MO) was used at a final concentration of 200 mM. Cell counting was performed on hematocytometer and error reported as the standard deviation between three separate manual counts. In order to control for potential differences in the phenomena under study, we utilized three different melanoma cell lines. The data presented for each of the three lines represent single experiments, not averages of triplicate experiments.
Flow cytometry
Flow cytometry with Hoechst 33342 was undertaken in a manner similar to that previously described (Goodell et al., 1996) , with a few modifications. Briefly, cells were trypsinized from flasks and resuspended to a concentration of 1 Â 10 6 cells/ml in media containing 2.5 mg/ml Hoechst 33342 (Sigma) and maintained at 
GFP labeling of the tumor lines
Tumor cells were transduced using an EGFP (enhanced GFP) lentiviral system. The plasmids were a generous gift from Bryan R. Cullen PhD (Lee et al., 2003) . The infective particles were produced by co-transfecting plasmids pNL-SIN-EGFP (2.0 mg), pcRev (100 ng), pcTat (100 ng), and pHIT/G (50 ng) in the presence of FuGENE 6 (Roche Diagnostics, Basel, Switzerland) into 5 Â 10 5 293T cells in each well of a six-well plate coated with poly-L-lysine (BD Biosciences). The media were changed after overnight incubation and 48 hours later the GFP lentivirus-containing media were sterile filtered (0.45 mm; Corning) and transferred to 5 Â 10 5 DM1N, DM2N, and DM3N cells also plated in a six-well plate. After 24 hours and again after 48 hours, the media were changed and the GFP-expressing cells were isolated on day 3 by FACS. Thereafter, the cells were carried in culture under similar conditions as those of the nontransduced lines.
BrdU staining of cultured melanoma cells
Cells cultured on 24 mm Thermox tissue culture coverslips were treated with 10 mM BrdU for 90 minutes, fixed with 70% EtOH for 20 minutes, incubated in 2.5 N HCl for 3 hours, and then neutralized in TBE, pH 8.0, for 5 minutes. Incorporated BrdU was visualized by incubating the cells with mouse monoclonal anti-BrdU (Sigma) at 1/ 200 dilution in phosphate-buffered saline and 1.5% normal horse serum for 1 hour at 371C. Bound antibody was detected using the avidin-biotin-peroxidase complex method (ABC kit, Vector, Burlingame, CA) and 3-amino-9-ethylcarbazole (Vector) as the chromogen. Sections were counterstained with hematoxylin (Fisher, Pittsburgh, PA). Cells were imaged through an Olympus BX41 microscope using the QFire camera and QCapture software (Olympus, Tokyo, Japan). Four representative fields (averaging 100-200 cells each) photographed through the Â 10 lens were analyzed for each of the three melanoma lines. The images were printed on an HP color LaserJet 4600dn printer (Hewlett Packard, Boise, ID). Nuclei were traced onto transparency film and separated into ''small'' and ''large'' subgroups using a size template that was created to separate the groups into roughly equal halves. This same size template was used for all three lines. The transparencies were then re-matched with the original prints and the red nuclei were scored as positive. Syncytia with three or more nuclei were not included. The standard deviation was differences in the counts on the four representative fields.
Fontana-Masson staining
Sorted cells were affixed to Super Frost plus glass slides (Esco, Portsmith, NH) by cytospin centrifugation, fixed in formalin, and treated with 3.3% silver amine solution for 90 minutes at 601C, 0.2% gold chloride for 10 minutes at room temperature, 5% sodium thiosulfate for 5 minutes, and counterstained with nuclear fast red (Sigma).
Fluorescence antibody staining
Primary antibodies included those targeted against nestin (3k1, Abcam, Cambridge, MA), gp100 (NKI-beteb, Monosan-Caltag, Burlingame, CA), mart-1 (m2-7c10/m2-7e3, Zymed, South San Francisco, CA), smooth muscle actin (Sigma), and NGFR (C40-1457, PE labeled, BD Pharmingen, San Diego, CA). Secondary antibodies were anti-IgG 1 , IgG 2a , and IgG 2b (FITC, Cy3-labeled Cal Tag). Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton. Cells were stained with primary antibodies (1:100) for 45 minutes at room temperature and secondary antibodies (1:400) for 20 minutes at room temperature in 1.5% horse serum and 1% bovine serum albumin in phosphate-buffered saline. The nuclei were counterstained with Hoechst 33342 dye (1 mg/ml). Negative controls were handled identically but lacked the primary antibodies. The stained cells were imaged on Olympus BX41 microscope using the QFire camera and QCapture software (Olympus). Photoshop elements s software was used to adjust brightness and contrast and to overlay the individual color images into multicolor composites.
Murine window
The murine window experiments were carried out under an approved Institutional Animal Care and Use Committee (IACUC) protocol. Nude mice (NCI, Frederick, MD) were utilized for these studies. The surgical technique and placement of the window devices was carried out as described previously (Shan et al., 2004) . Melanoma cells were sorted by flow cytometry, pelleted, and resuspended in media at a concentration of 1 Â 10 6 cells/ml. Approximately 40 ml was injected into the murine skin and then covered with a clear coverglass insert. At follow-up time points, the tissue was examined through the coverglass on a Carl Zeiss MPS intravital microscope and the cells/tumor imaged as previously described (Shan et al., 2004) .
